Medical News
Ravulizumab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial
New England Journal of Medicine - 23 Oct 2026 04:31
New England Journal of Medicine, Volume 395, Issue 19, Page 1921-1931, November 12, 2026.
Interim Analysis of a Phase 3 Trial of Povetacicept in IgA Nephropathy
New England Journal of Medicine - 23 Oct 2026 04:30
New England Journal of Medicine, Ahead of Print.
Ravulizumab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial
New England Journal of Medicine - 23 Oct 2026 04:30
New England Journal of Medicine, Ahead of Print.